PMID: 6537915Jan 1, 1984Paper

The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring

European Journal of Cancer & Clinical Oncology
H van SlootenD Smeenk

Abstract

Thirty-four patients with adrenocortical carcinoma were treated with o,p'-DDD. Twenty-eight patients presented with metastases at entry, and spillage of tumour cells occurred at surgery in 6 other patients. Eight patients had objective tumour regression, of whom 7 had serum levels over 14 micrograms/ml. The 3 patients with a lasting remission had levels of greater than 15, greater than 25, greater than 25 micrograms/ml respectively during prolonged periods. Increased survival times were found in the group of 14 patients with o,p'-DDD serum levels higher than 14 micrograms/ml when compared with patients not treated after discovery of metastases. In the patients with levels less than or equal to 10 micrograms/ml no therapeutic effect was seen. Levels of over 20 micrograms/ml are associated with symptoms of reversible neuromuscular toxicity. Monitoring of serum levels during treatment is mandatory. It is suggested that serum levels of about 25 micrograms/ml during longer periods may be curative.

References

Aug 1, 1976·Acta Radiologica: Therapy, Physics, Biology·B Percarpio, A H Knowlton
Dec 1, 1978·Irish Journal of Medical Science·P McKiernanD K O'Donovan
Apr 15, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·A J MoolenaarI T Oei
Sep 1, 1975·Archives of Internal Medicine·J A Ostuni, M S Roginsky
Mar 5, 1973·JAMA : the Journal of the American Medical Association·J A LubitzR Okun
Jan 1, 1972·The Journal of Clinical Endocrinology and Metabolism·N HaqueL J Sholiton
Jan 1, 1982·Cancer Chemotherapy and Pharmacology·H von SlootenA J Moolenaar
Sep 1, 1963·The American Journal of Medicine·M B LIPSETTG T ROSS
Dec 1, 1964·The Journal of Clinical Endocrinology and Metabolism·T BLEDSOEG W LIDDLE

❮ Previous
Next ❯

Citations

Jan 1, 1992·Cancer Chemotherapy and Pharmacology·D O GebhardtJ A Gevers Leuven
Jan 1, 1996·International Urology and Nephrology·E D FokaefsG A Barbalias
Sep 27, 2001·World Journal of Surgery·A P DackiwD B Evans
Sep 27, 2001·World Journal of Surgery·H AhlmanS Lindstedt
Dec 1, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·M InouyeK Sumino
Sep 13, 1990·The New England Journal of Medicine·H R HaakA J Moolenaar
Aug 31, 2012·Journal of Oncology·Antonio StiglianoVincenzo Toscano
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irina VeytsmanTito Fojo
Oct 10, 2008·The Journal of Clinical Endocrinology and Metabolism·Hui Huang, Tito Fojo
Jul 21, 2012·European Journal of Endocrinology·Camille BaudryJérôme Bertherat
Jan 8, 2011·The Oncologist·Lyndal J TaconStan B Sidhu
Jul 4, 2009·Clinical Medicine & Research·Sreelatha ChalasaniAlan K McKenzie
May 29, 2008·European Journal of Endocrinology·I G C HermsenH R Haak
Jun 4, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Angelo PaciEtienne Chatelut
Jun 25, 2014·Critical Reviews in Oncology/hematology·André P FayToni K Choueiri
Jul 15, 2015·Journal of Endocrinological Investigation·A StiglianoM Terzolo
Jul 2, 2011·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Madhu B GargStephen P Ackland
Oct 20, 2009·The Surgical Clinics of North America·Melissa WandoloskiMichael J Demeure
Jun 6, 2007·Hematology/oncology Clinics of North America·Alexandria T Phan
Aug 3, 2006·Surgical Oncology Clinics of North America·Steven E RodgersNancy D Perrier
Mar 5, 2005·Pediatric Blood & Cancer·Carlos Rodriguez-GalindoRaul C Ribeiro
Apr 11, 2012·Journal of Surgical Oncology·Robert Dreicer
Sep 3, 2011·BJU International·Renata CostaDerek Raghavan
May 29, 2009·Clinical Endocrinology·Krystallenia I AlexandrakiAshley B Grossman
Apr 28, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R C Ribeiro, B Figueiredo
Sep 4, 2008·Expert Opinion on Emerging Drugs·Alfredo BerrutiMassimo Terzolo
Jan 1, 2008·Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology·Takako GotoToshiro Hara
Feb 1, 2015·European Journal of Endocrinology·Eleni Daniel, John D C Newell-Price
Nov 6, 2012·Journal of Oncology·Amir H LebastchiTobias Carling
Apr 26, 1990·The New England Journal of Medicine·J P LutonP Blondeau
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reinaldo ChacónMatías Chacón
Apr 23, 2017·Biomedical Chromatography : BMC·Catherine FeliuZoubir Djerada
Jun 3, 2014·Therapeutic Drug Monitoring·Thomas M A KerkhofsHarm R Haak
Feb 17, 2018·The Journal of Clinical Endocrinology and Metabolism·Felix MegerleUNKNOWN German ACC Study Group
Sep 3, 2018·BMJ Case Reports·Ali U FarooqSubash Adhikari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.